Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.52 |
| ▸ | SQLE | Q14534 | 6/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15257167 | 1.00 | ALDH1A1 (0.61) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 | |
| SCHEMBL5323637 | 1.00 | ALDH1A1 (0.61) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 | |
| SCHEMBL3274058 | 1.00 | ALDH1A1 (0.61) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 | |
| SCHEMBL15255046 | 1.00 | ALDH1A1 (0.61) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 | |
| SCHEMBL13870979 | 0.96 | KMT2A (0.67) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 | |
| SCHEMBL3275116 | 0.96 | KMT2A (0.67) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 | |
| SCHEMBL30096335 | 0.85 | ALDH1A1 (0.55) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 | |
| SCHEMBL15257168 | 0.82 | KDM4E (0.44) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 | |
| SCHEMBL28575170 | 0.80 | NR1I2 (0.76) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 | |
| SCHEMBL25396940 | 0.78 | ALDH1A1 (0.64) | ALDH1A1KMT2AKDM4EMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3725782-B1 | NOVEL METHOD FOR PRODUCING 5,5-DISUBSTITUTED-4,5-DIHYDROISOXAZOLE | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2022-06-22 | — | — | EP | disclosed |
| US-10975041-B2 | Method for producing 5, 5-disubstituted-4, 5-dihydroisoxazole | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2021-04-13 | — | — | US | disclosed |
| US-20210047280-A1 | NOVEL METHOD FOR PRODUCING 5, 5-DISUBSTITUTED-4, 5-DIHYDROISOXAZOLE | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2021-02-18 | — | — | US | disclosed |
| EP-3725782-A1 | NOVEL METHOD FOR PRODUCING 5,5-DISUBSTITUTED-4,5-DIHYDROISOXAZOLE | Kumiai Chemical Industry Co., Ltd. (JP) | 2020-10-21 | — | — | EP | disclosed |
| EP-2825661-B1 | PROCESS FOR PREPARING TERPENE NITRILES FROM TERPENE OXIMES EMPLOYING AN ALDOXIME DEHYDRATASE | BASF SE (DE) | 2016-05-18 | — | — | EP | disclosed |
| US-9080191-B2 | Method for biocatalytic production of nitriles from oximes and oxime dehydratases usable therein | BASF SE (DE) | 2015-07-14 | — | — | US | disclosed |
| US-9080191-B2 | Method for biocatalytic production of nitriles from oximes and oxime dehydratases usable therein | BASF SE (DE) | 2015-07-14 | — | — | US | disclosed |
| US-9080191-B2 | Method for biocatalytic production of nitriles from oximes and oxime dehydratases usable therein | BASF SE (DE) | 2015-07-14 | — | — | US | disclosed |
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2013-10-10 | — | — | US | disclosed |
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2013-10-10 | — | — | US | disclosed |
| US-20130244298-A1 | METHOD FOR BIOCATALYTIC PRODUCTION OF NITRILES FROM OXIMES AND OXIME DEHYDRATASES USABLE THEREIN | BASF SE (DE) | 2013-09-19 | — | — | US | disclosed |
| US-20130244298-A1 | METHOD FOR BIOCATALYTIC PRODUCTION OF NITRILES FROM OXIMES AND OXIME DEHYDRATASES USABLE THEREIN | BASF SE (DE) | 2013-09-19 | — | — | US | disclosed |
| US-20130244298-A1 | METHOD FOR BIOCATALYTIC PRODUCTION OF NITRILES FROM OXIMES AND OXIME DEHYDRATASES USABLE THEREIN | BASF SE (DE) | 2013-09-19 | — | — | US | disclosed |
| WO-2012034232-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2012-03-22 | — | — | WO | disclosed |
| US-20090092642-A1 | Skin and/or Hair Products, Containing Compounds With an Isoprenoid Structure | BEIERSDORF AG (DE) | 2009-04-09 | — | — | US | disclosed |
| US-20090092642-A1 | Skin and/or Hair Products, Containing Compounds With an Isoprenoid Structure | BEIERSDORF AG (DE) | 2009-04-09 | — | — | US | disclosed |
| WO-2005102252-A9 | SKIN AND/OR HAIR PRODUCTS, CONTAINING COMPOUNDS WITH AN ISOPRENOID STRUCTURE | BEIERSDORF AG (DE) | 2007-01-11 | — | — | WO | disclosed |
| WO-2005102252-A9 | SKIN AND/OR HAIR PRODUCTS, CONTAINING COMPOUNDS WITH AN ISOPRENOID STRUCTURE | BEIERSDORF AG (DE) | 2007-01-11 | — | — | WO | disclosed |
| US-5892092-A | BY DEHYDRATION OF THE CORRESPONDING OXIME | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047280-A1 | NOVEL METHOD FOR PRODUCING 5, 5-DISUBSTITUTED-4, 5-DIHYDROISOXAZOLE | CYP3A5, CYP4X1, SQLE | ALDH1A1 185/4885KMT2A 3360/4885KDM4E 2024/4885 |
| US-10975041-B2 | Method for producing 5, 5-disubstituted-4, 5-dihydroisoxazole | CYP3A5, CYP4X1, SQLE | ALDH1A1 149/4885KMT2A 2989/4885KDM4E 1721/4885 |
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | PMP22, PTGES, GGPS1 | ALDH1A1 1584/4885KMT2A 3842/4885KDM4E 3901/4885 |
| US-20090092642-A1 | Skin and/or Hair Products, Containing Compounds With an Isoprenoid Structure | SRD5A2, SRD5A1, CUTA | ALDH1A1 2012/4885KMT2A 3935/4885KDM4E 2169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.